The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats

European Journal of Pharmacology

Volumn 158, Issue 1-2, 1988, Pages 61-67

  Sikirić, Predrag ^a   Rotkvić, Ivo ^b   Miše, Stjepan ^d   Križanac, Šimun ^b   Gjuriš, Veljko ^a   Jukić, Jerka ^c   Suchanek, Ernest ^a   Petek, Marijan ^a   Udovičić, Ivan ^e   Kalogjera, Livije ^a   Geber, Juraj ^a   Tućan Foretić, Milica ^a   Duvnjak, Marko ^c   Philipp, Miroslav ^a   Balen, Ivan ^f   Anić, Tomislav ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c Department of Gynaecology Medical Faculty University of Zagreb ^*  (Croatia)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

^e Department of Internal Medicine General Hospital 'Dr J Kajfeš' University Hospital 'Zagreb' ^*  (Croatia)

^f Department of Surgery General Hospital 'Dr J Kajfeš' University Hospital 'Zagreb' ^*

Author keywords

(Aggravation, Protection); Dopamine receptor agonists; Dopamine receptor antagonists; Indomethacin; Intestinal lesions; Stomach lesions

Indexed keywords

AMANTADINE; BROMOCRIPTINE; DOMPERIDONE; DOPAMINE RECEPTOR; HALOPERIDOL; INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; FEMALE; HISTOLOGY; INTESTINE INJURY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH LESION;

ANIMAL; ANTI-ULCER AGENTS; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; GASTRIC MUCOSA; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RATS; RATS, INBRED STRAINS; STOMACH ULCER; ULCER;

EID: 0024210651     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(88)90253-1     Document Type: Article

References (33)

1. Haloperidol decanoate. A preliminary review of its pharmacodinamic and pharmacokinetic properties and therapeutic use in psychosis
2. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the pemeability of the human small intestine
3. Monoamine storing cells of the enterochromaffin type in gastrointestinal tract of human fetus
4. Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in rats
5. Metoclopramide. An updated review of its pharmacological properties and clinical use
6. Prevention of stress induced gastric ulcers by dopamine agonists in the rat
7. Minireview. Neuroendocrine mechanisms of stress ulceration: Focus on thyrotropin-releasing hormone (TRH)
8. New drugs for healing ulcers
9. Intravenous indomethacin and aspirin induced basal gastric mucosal blood flow in dogs
10. 1 antagonist activity of domperidone in the periphery
11. Dopamine produces vasolidation in specific regions and layers of the rabbit gastrointestinal tract
12. Blood flow redistribution by dopamine in the feline gastrointestinal tract
13. Treatment of duodenal ulcer with antacid and sulpiride
14. Uptake and metabolism of L-3,4-dihidroxyphenylalanine (DOPA) in rat tissues
15. Role of blood flow in gastric and duodenal mucosal injury in the rat
16. Endogenous gastric mucosal prostaglandins: Their role in mucosal integrity
17. Intestinal function and intestinal blood supply: a 20 year surgical study
18. Amantadine
19. Effect of bromocriptine, a dopamine receptor agonist on the experimentally induced gastric ulcers in albino rats
20. Metoclopramide: A review of its pharmacological properties and clinical use
21. 2 on gastric secretion in the rat
22. The importance of nervous and humoral factors in the control of vascular resistance, blood flow distribution and net fluid absorption in the cat small intestine during hemorrhage
23. An intestinal disease produced experimentally by a prostaglandin deficiency
24. Cytoprotection and adapted cytoprotection
25. The role of dopamine in the formation of gastric ulcers in rats
26. Dopamine antagonists induce gastric lesions in rats
27. The influence of dopamine agonists and antagonists on gastric lesions in mice
28. Newer antisecretory agents for peptic ulcer
29. Dopamine disorder in duodenal ulceration
30. Dopamine agonists and antagonists in duodenal ulcer disease
31. Dopamine is an important neurotransmitter in the autonomic nervous system
32. Ulcerogenic and antiulcerogenic effects of a new antiinflammatory drug. The γ-lactone-N-ethyl derivative of 6-[1S-(3S-4-dihidro-8-hydroxy-1H-2- benzopyran-1-one-3-yl)-3-methylbutylamino]-4S,5S-dihidroxy-6-oxo-3-S-ammoniohexanoate, on gas trointestinal tract in rats
33. Mechanisms underlying gastric mucosa damage induced by indomethacin and bile salts, and the actions of prostaglandins